BioSpace News Archive

Supply Chain Issues, the Need for Additional Talent Chemists, Lower Drug Prices, Growth of Development in the U.S. Will Be Key Factors.

Chosen among thousands of companies appearing at CES® this year, Engadget awarded Olive Union’s Smart Ear “Best Wearable” in the International CES 2020 “Best of CES Awards” based on innovation, quality of design, overall efficiency and market demand.

SparingVision, a biotechnology company innovating treatment of blinding inherited retinal diseases such as Retinitis Pigmentosa and pioneer in the development of a gene-independent treatment for retinitis pigmentosa, attends the Biotech Showcase in San Francisco to meet with investors and strategic partners.

Barrett will facilitate continued growth and collaboration with teams dedicated to delivering a world-class customer experience.

New requirements of the Safe Food for Canadians Regulations come into force for most businesses in the fresh fruits or vegetables sector that import, export or engage in interprovincial trade.

Definitive Healthcare, the leading provider of data, insights, and analytics on the healthcare provider market, today announced the acquisition of PatientFinder, a software analytics firm that helps life science companies and healthcare providers find patient clusters who would most benefit from their products and services.

Today, HRA Pharma has announced the next phase of its international expansion into China, the second largest and most dynamic consumer healthcare (CHC) market in the world.

Ergomed plc (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialised services to the pharmaceutical industry, today announces the acquisition of Ashfield Pharmacovigilance Inc. (“Ashfield PV”), a specialist pharmacovigilance services provider based in Cary in the Research Triangle, North Carolina, USA (the “Acquisition”) from UDG Healthcare US Holdings, Inc., the US operating subsidiary of UDG Healthcare plc (“UDG” or the “Seller”).

AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies (SAITs), today announced a realignment of its development strategy on neurodegenerative diseases, a core area of expertise of the company.

Crescendo Biologics Ltd, the drug developer of novel, targeted, T cell enhancing therapeutics, announces the publication of a paper that demonstrates greater tissue penetration and in vivo efficacy of Humabody® VH therapeutics compared to conventional antibody formats, in the scientific journal Cancer Research a journal of the American Association for Cancer Research.